Skip to main content
Tech.euFundingExplorerBeta

Quidditas

Quidditas developed a novel genome editing platform which permits an absolute genetic recombination.

Quidditas has raised €2.6M across 1 funding round from 5 investors, most recently a round in May 2025. Based in Liège, France; active in Healthtech. Data as of 28 Oct 2026.

Liège, Francewww.quidditastherapeutics.com ↗
Healthtech
← All companies
Total raised
€2.6M
€2,620,000
Funding rounds
1
Investors
5
distinct backers
Active since
2025-05
latest 2025-05

Funding by year

EUR raised per year
Quidditas — funding by year — interactive chart.
Data table
Quidditas — funding by year
2025€2.6M

Signals

High confidence
Raise-next likelihood41
base rate 30% for Other
  • ▲ In typical raise window
  • ▼ Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2025-05-12Other€2.6MBusiness Angels,family businesses,iXLife,Key Capital,the Ministry of Research in WalloniaView deal →

Investors

5
Business Angelsfamily businessesiXLifeKey Capitalthe Ministry of Research in Wallonia

Related news

Similar companies

same sector or country

Global coverage: FundingData